US Department of Justice, Drug Enforcement Agency, Diversion Control Program. Drugs and Chemicals of Concern: Salvia Divinorum, ska Maria Pastora, Salvia (Salvinorin A, Divinorin A). 2002. Available at: https://www.deadiversion.usdoj.gov/drugs_concern/salvia_d/summary.htm
Valdes LJ 3rd, Diaz JL, Paul AG. Ethnopharmacology of ska Maria Pastora (Salvia divinorum, Epling and Jativa-M.). J Ethnopharmacol 1983;7:287-312.
Valdes LJ 3rd. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A. J Psychoactive Drugs 1994;26:277-83.
Siebert DJ. Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 1994;43:53-6.
Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States.
Pharmacol Ther 2004; 102:131-8.
Gonzalez D, Riba J, Bouso JC, et al. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend 2006;85:157-62.
Singh S. Adolescent salvia substance abuse. Addiction 2007;102:823-4.
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., and Rothman, R. B. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad.Sci U.S.A 9-3-2002;99(18):11934-11939.
Butelman, E. R., Harris, T. J., and Kreek, M. J. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology (Berl) 2004;172(2):220-224.
Bucheler, R., Gleiter, C. H., Schwoerer, P., and Gaertner, I. Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage). Pharmacopsychiatry 2005;38(1):1-5.
Pichini, S., Abanades, S., Farre, M., Pellegrini, M., Marchei, E., Pacifici, R., Torre, Rde L., and Zuccaro, P. Quantification of the plant-derived hallucinogen Salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking. Rapid Commun.Mass Spectrom. 2005;19(12):1649-1656.
Capasso, R., Borrelli, F., Capasso, F., Siebert, D. J., Stewart, D. J., Zjawiony, J. K., and Izzo, A. A. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum. Neurogastroenterol.Motil. 2006;18(1):69-75.
Ansonoff, M. A., Zhang, J., Czyzyk, T., Rothman, R. B., Stewart, J., Xu, H., Zjwiony, J., Siebert, D. J., Yang, F., Roth, B. L., and Pintar, J. E. Antinociceptive and Hypothermic Effects of Salvinorin A Are Abolished in a Novel Strain of {kappa}-Opioid Receptor-1 Knockout Mice. J Pharmacol Exp Ther 2006;318(2):641-648.
Addy PH, Garcia-Romeu A, Metzger M, Wade J. The subjective experience of acute, experimentally-induced Salvia divinorum inebriation. J Psychopharmacol. 2015;29(4):426-35.
El-Khoury J, Sahakian N. The association of Salvia divinorum and psychotic disorders: A review of the literature and case series. J Psychoactive Drugs. 2015;47(4):286-92.
Vázquez-León P, Arenas-Martínez U, Córdova-Maqueda D, Fregoso-Aguilar T, Ramírez-San Juan E, Miranda-Páez A. Salvia divinorum increases alcohol intake and tonic immobility whilst decreasing food intake in Wistar rats. Acta Neurobiol Exp (Wars) 2021;81(1):34-42.
Doss MK, May DG, Johnson MW, et al. The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain. Sci Rep 2020;10(1):16392.